5 High Growth Healthcare Stocks to Buy
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) is one of the high growth healthcare companies that is working on treatments for neuropsychiatric and neurologic disorders.
Intra-Cellular Therapies Inc. (ITCI)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Is Intra-Cellular Therapies (ITCI) a Worthy Investment Option?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” third-quarter investor letter. A copy of the same can be downloaded here.
Should You Retain Your Holdings in Intra-Cellular Therapies (ITCI)?
Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Ultra Strategy” third-quarter 2022 investor letter. A copy of the same can be downloaded here.
Is Intra-Cellular Therapies (ITCI) Stock a Worthy Buy?
ClearBridge Investments, an investment management company, published its “ClearBridge Small Cap Growth Strategy” third quarter 2022 investor letter. A copy of the same can be downloaded here.
Wasatch Global's Strongest Q1 Contributor: Intra-Cellular Therapies (ITCI)
Wasatch Global Investors, an investment management firm, published its “Wasatch Ultra Growth Fund” first quarter 2022 investor letter – a copy of which can be downloaded here.
Is it a Great Choice to Invest in Intra-Cellular Therapies, Inc. (ITCI)?
ClearBridge Investments, an investment management firm, published its “Small Cap Strategy” fourth quarter 2021 investor letter – a copy of which can be downloaded here.
Should You Consider Investing in Intra-Cellular Therapies (ITCI)?
Wasatch Global Investors, an investment management firm, published its “Wasatch Small Cap Growth Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.
Hedge Funds Are Warming Up To Intra-Cellular Therapies Inc (ITCI)
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Should You Consider Investing in Intra-Cellular Therapies (ITCI)?
Wasatch Global Investors, an investment management firm, published its “Wasatch Ultra Growth Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
Is ITCI Stock A Buy or Sell?
In this article we will check out the progression of hedge fund sentiment towards Intra-Cellular Therapies Inc (NASDAQ:ITCI) and determine whether it is a good investment right now.
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
